Zurueck zur Suche

Reporte zur Charge U7273BB

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

11Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
TX 3 NE 2 AZ 1 NV 1 IL 1 OR 1 NY 1 TN 1

VAERS 2538046

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENACTRA) · Charge U7273BB

schwer
Staat
AZ
Alter
12,0
Geschlecht
M
Eingang
20.12.2022
Impfdatum
20.12.2022
Beginn
20.12.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Loss of consciousness Syncope

Symptomtext

Vasovagal syncope after Tdap and meningococcal vaccination. Occurred at approximately 1510. Pt was unconscious for 3-5 seconds, no fall or injury occurred as patient was sitting in chair. Pt was placed in supine position and ice bags were placed on neck and forehead. Patient fully recovered by 1517.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
12/20/2022 @1517 Vitals were taken and pt was observed by RN and PCP and discharged home w/ Father.
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
No current meds
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2388880

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENACTRA) · Charge U7273BB

schwer
Staat
NV
Alter
15,0
Geschlecht
M
Eingang
25.07.2022
Impfdatum
25.07.2022
Beginn
25.07.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dehydration Heart rate decreased Hypotension Syncope

Symptomtext

SYNCOPE SEVERAL TIMES WITHIN 20 MINUTES...PT WAS DEHYDRATED... LOW BP AND PULSE RATE.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
ASTHMA
Vorgeschichte
ASTHMA
Andere Medikamente
NKA
Allergien
NKA
Vorherige Impfungen
-

VAERS 2460529

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENACTRA) · Charge U7273BB

mild
Staat
IL
Alter
17,0
Geschlecht
F
Eingang
26.09.2022
Impfdatum
19.09.2022
Beginn
19.09.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Blood glucose Dizziness Feeling of body temperature change Hyperhidrosis Pallor

Symptomtext

Patient received vaccinations without incident. However, she returned to clinic several hours later complaining of feeling dizzy and lightheaded. She also reports that her she'd feel cold one moment and then hot another. Patient did not eat anything all day. Blood sugar was 83. Pulse: 83, Blood pressure: 102/70, Resp Rate: 18, Temp: 97.9. She was diaphoretic and pale when she first returned. Otherwise, physical exam was unremarkable. She stayed with us for ~45 min. Was given graham crackers and water. After sitting and eating, her coloring appeared more at baseline. She reported feeling better. Family was called and notified. She left clinic for home with instructions to monitor closely.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
Blood sugar: 83
Aktuelle Erkrankungen
Non
Vorgeschichte
Scoliosis, chronic right ankle pain
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2410728

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENACTRA) · Charge U7273BB

mild
Staat
OR
Alter
17,0
Geschlecht
F
Eingang
12.08.2022
Impfdatum
10.08.2022
Beginn
10.08.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Fatigue Headache Injection site erythema Injection site pain

Symptomtext

pain and redness at injection site, headache and fatigue

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2633327

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENACTRA) · Charge U7273BB

gering
Staat
TX
Alter
18,0
Geschlecht
U
Eingang
18.05.2023
Impfdatum
01.05.2023
Beginn
01.05.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Medication error No adverse event

Symptomtext

A Pharmacist reported that over the weekend an expired dose of MENACTRA was given to a consumer with no reported adverse event; Initial information received on 15-May-2023 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a 18 years old patient of an unknown gender and a pharmacist reported that over the weekend an expired dose of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] was given to a consumer with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date in May 2023, the patient received a 0.5 ml dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE for solution of injection (strength, frequency: not reported and expiry date: 24-apr-2023, lot: U7273BB) via intramuscular route in the arm NOS for immunization and a pharmacist reported that over the weekend an expired dose of menactra was given to a consumer with no reported adverse event (expired product administered) (latency: same day). Action taken: not applicable. It was not reported if the patient received a corrective treatment for the event. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2626998

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENACTRA) · Charge U7273BB

gering
Staat
TX
Alter
18,0
Geschlecht
F
Eingang
05.05.2023
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

administered an expired menactra to a patient with no reported adverse event; Initial information received on 28-Apr-2023 regarding an unsolicited valid non-serious case received from other health professional. This case involves an 18 years old female patient who was administered an expired Meningococcal A-C-Y-W135 (D CONJ) vaccine [MENACTRA]to a patient with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received an unknown dose of suspect Meningococcal A-C-Y-W135 (D CONJ) vaccine Solution for injection of lot U7273BB and expiry: 24-Apr-2023 via unknown route in unknown administration site for Immunization. On an unknown date, the patient developed a non-serious event administered an expired MENINGOCOCCAL A-C-Y-W135 (D CONJ) Vaccine to a patient with no reported adverse event (expired product administered) (latency: 1 day). No lab data was reported. Action taken was not applicable. At time of reporting, the outcome was Unknown for the event administered an expired menactra to a patient with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2623192

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENACTRA) · Charge U7273BB

gering
Staat
TX
Alter
18,0
Geschlecht
F
Eingang
28.04.2023
Impfdatum
27.04.2023
Beginn
28.04.2023
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Vaccine given was expired. Expiration on the dose was 4-24-23

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2440036

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENACTRA) · Charge U7273BB

gering
Staat
NY
Alter
12,0
Geschlecht
M
Eingang
10.09.2022
Impfdatum
29.08.2022
Beginn
29.08.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SYR / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered

Symptomtext

Parent called to schedule meningitis vaccine for school as she received a letter from school nurse stating he required it to start school Sept 2022. One staff nurse scheduled visit, patient was new to practice and was awaiting transfer of previous office records. Upon visit to office for injection a second staff nurse gave vaccine without looking up history, after it was found that patient received Menveo one year prior in 7.2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
none to office knowledge
Vorgeschichte
ADHD, asthma, constipation
Andere Medikamente
Focalin 10 mg Qam, 15 mg Qnoon Risperidone 0.5 mg BID Clonidine 0.1 mg Qam, Qnoon, 0.2 mg Qhs Melatonin 5 mg Qhs PRN
Allergien
none
Vorherige Impfungen
-

VAERS 2405547

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENACTRA) · Charge U7273BB

gering
Staat
TN
Alter
0,3
Geschlecht
F
Eingang
09.08.2022
Impfdatum
02.08.2022
Beginn
02.08.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

received a dose of menactra at 4 months and 3 days old(with no reported adverse event); Initial information received on 02-Aug-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 4 months 3 days old female patient who received a dose of menactra with no reported adverse event while receiving vaccine MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA]. The patient's past medical history, medical treatment(s), and family history were not provided. Concomitant medications included ROTAVIRUS VACCINE LIVE REASSORT ORAL 5V (ROTATEQ) for Immunisation; and PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) (PREVNAR) for Immunisation. On 02-Aug-2022, the patient received a dose number 1 of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE( lot U7273BB and expiration date: 24-Apr-2023) at a dose of 0.5ml via intramuscular route in the left thigh for immunization. On 02-Aug-2022 (latency: same day) , the patient received a dose of menactra with no reported adverse event (product administered to patient of inappropriate age) following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE. Action taken :not applicable It was not reported if the patient received a corrective treatment for the event (received a dose of menactra at 4 months and 3 days old(with no reported adverse event)). Outcome: unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2397774

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENACTRA) · Charge U7273BB

gering
Staat
NE
Alter
12,0
Geschlecht
M
Eingang
01.08.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
2
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Wrong product administered

Symptomtext

Menactra was grabbed as mistake and administered to the patient, 12 yo patient who was given a second dose of Menactra. The first dose was given at age 11 with no reported adverse event; Initial information received on 22-Jul-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 12 years old male patient by whom Menactra was grabbed as mistake and administered to the patient, 12 yo patient who was given a second dose of Menactra. The first dose was given at age 11 with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a 0.5 ml (once) dose of suspect Meningococcal A-C-Y-135 (D Conj) Vaccine (lot U7273BB, expiry date; 24-Apr-2023, formulation, strength: unknown) via intramuscular route at administration site left (unspecified) for immunization or Tuberculin skin test. On an unknown onset and latency, It was reported Menactra was grabbed as mistake and administered to the patient, 12 yo patient who was given a second dose of Menactra. The first dose was given at age 11 with no reported adverse event (wrong product administered). Action taken: Not applicable. Outcome: Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2388387

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENACTRA) · Charge U7273BB

gering
Staat
NE
Alter
12,0
Geschlecht
M
Eingang
25.07.2022
Impfdatum
22.07.2022
Beginn
-
Tage bis Beginn
-
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Inappropriate schedule of product administration Wrong product administered

Symptomtext

No adverse reaction patient was given first dose at age 11 and 4 months was to receive gardasil today but MCV4 was given instead at age 12 years 9 months by mistake Contacting parent regarding vaccine and also spoke to medical at Sanofi pasteur Regarding patient receiving 2nd dose one year five months later after first dose

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-